CD4+ T 细胞介导MHC缺乏的瘤排斥和内皮细胞重编程
Samuel I Kim1, Margaret E Haerr2,3, Maryam Al-Ghezi3
1Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer immunology research
|September 30, 2025
概括
缺乏MHC表达的瘤细胞仍然可以通过组合免疫疗法准. 这种方法依赖于CD4+ T细胞,而不是CD8+ T细胞,以重塑瘤微环境以进行免疫排斥.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 瘤细胞上MHC表达率低或不存在是免疫治疗耐药性的可疑机制.
- 在没有瘤MHC表达的情况下,免疫治疗的有效性尚未得到充分理解.
研究的目的:
- 研究瘤MHC表达在免疫疗法反应中的作用.
- 确定免疫细胞类型对免疫疗法疗效至关重要.
- 探索独立于瘤MHC表达的瘤排斥机制.
主要方法:
- 基因工程小鼠瘤细胞具有不同的MHC表达.
- 皮下瘤植入于同基因小鼠.
- 组合免疫疗法 (抗CD40,抗PD-1,抗CTLA-4) 的使用.
- 免疫细胞群 (CD4+,CD8+T细胞) 和分子通路的分析.
主要成果:
- 在没有免疫治疗的情况下,MHC I 类缺陷瘤逐渐生长.
- 组合免疫疗法对缺乏MHC I类,MHC II类或IFNγ受体的瘤有效.
- CD4+ T 细胞,但不是 CD8+ T 细胞,对于治疗反应至关重要.
- 观察到包括内皮细胞在内的MHCII类表达性树皮细胞的重编程.
结论:
- 瘤免疫监测并不严格要求瘤MHC I类或CD8+ T细胞.
- CD4+ T 细胞通过瘤外部机制调解瘤排斥,例如树皮细胞重编程.
- 组合免疫疗法可以克服与低/缺少瘤MHC表达相关的抵抗,突出CD4+T细胞驱动的免疫记忆.
更多相关视频
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
7.6K
10:04Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
1.4K
相关概念视频
01:22T Cell Activation and Clonal Selection
14.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K
01:40Cell-mediated Immune Responses
83.2K
Overview
83.2K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K